Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$392,986,942
+$107,386,034 QoQ
Shares Held
1,561,703
+18.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#101
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. ABBV ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,986,942 | 1,561,703 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $285,600,908 | 1,313,168 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $298,154,315 | 1,304,890 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $300,350,213 | 1,297,185 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $241,631,576 | 1,301,754 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $269,729,342 | 1,287,368 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $212,857,944 | 1,197,850 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $239,624,403 | 1,213,411 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $197,806,125 | 1,153,254 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $198,196,003 | 1,088,410 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $154,415,981 | 996,425 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $134,884,393 | 904,900 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $85,097,892 | 631,618 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $117,423,337 | 736,797 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $109,680,181 | 678,672 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $89,190,597 | 664,560 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $88,258,143 | 576,248 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $97,544,828 | 601,720 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $71,375,973 | 527,149 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $50,165,266 | 465,053 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $53,136,793 | 471,740 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $45,899,456 | 424,131 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $40,908,690 | 381,789 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $39,793,625 | 454,317 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $60,695,660 | 618,208 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $42,912,340 | 563,228 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||